z-logo
Premium
Single Molecular Wells–Dawson‐Like Heterometallic Cluster for the In Situ Functionalization of Ordered Mesoporous Carbon: A T 1 ‐ and T 2 ‐Weighted Dual‐Mode Magnetic Resonance Imaging Agent and Drug Delivery System
Author(s) -
Zhang Qianqian,
Wang Peiyuan,
Ling Yun,
Li Xiaomin,
Xia Lixue,
Yang Yongtai,
Liu Xiaofeng,
Zhang Fan,
Zhou Yaming
Publication year - 2017
Publication title -
advanced functional materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.069
H-Index - 322
eISSN - 1616-3028
pISSN - 1616-301X
DOI - 10.1002/adfm.201605313
Subject(s) - materials science , mesoporous material , nanoparticle , carbon fibers , surface modification , porosity , matrix (chemical analysis) , cluster (spacecraft) , in situ , chemical engineering , crystallography , nanotechnology , composite material , organic chemistry , chemistry , catalysis , composite number , computer science , engineering , programming language
Developing a feasible way to prepare highly dispersed heterometallic nanoparticles incorporated in porous carbon composites is of significant importance for multifunctional materials. In this work, heterometallic γ‐Fe 2 O 3 and GdPO 4 nanoparticles that are incorporated in ordered mesoporous carbon composites are facilely prepared by a one‐pot in situ method using a Wells–Dawson‐like cluster of [Fe 6 Gd 6 (μ 3 ‐O) 2 (CO 3 )(O 3 PPh) 6 (O 2 C t Bu) 18 ] ({Fe 6 Gd 6 P 6 } for short) as the precursor. It is verified that the γ‐Fe 2 O 3 and GdPO 4 nanoparticles are highly dispersed and embedded into the carbon matrix with a particle size smaller than 5 nm, even when the carbon matrix is changed from 2D hexagonal P6mm to 3D body‐centered cubic Im‐3m symmetry. Additionally, a formation mechanism is proposed. Furthermore, dual‐mode magnetic resonance (MR) imaging and drug carrier properties are evaluated by in vitro experiments, which show a satisfactory T 1 ‐ and T 2 ‐weighted MR imaging effect with r 1 and r 2 relaxivity values of 2.7 and 183.7 mM −1 s −1 , respectively, and doxorubicin hydrochloride carrier amount of 102 mg g −1 , identifying a combined function for potential diagnostic and therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom